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Abstracts / International Journal of Surgery 36 (2016) S31eS132S1226 sphincters were inserted. 60% of patients had no complications. 1 patient
(20%) had ileoinguinal nerve irritation at 2 months. 1 sphincter failed
mechanically at 15 months. This was replaced and the patient remained
dry at 24months. 4 out of 5 patients (80%) were dry at latest follow up; the
remaining patient used 2-3 pads per day, an improvement from 6 pads
with ﬂooding preoperatively.
Conclusion: In our experience the use of AUS is an effective and safe
treatment for incontinence in women with intrinsic sphincter deﬁciency
or inappropriate urethral relaxation. We anticipate increasing future use of
female AUS in our practice.http://dx.doi.org/10.1016/j.ijsu.2016.08.449
0144: A COMPARISON OF TRANS-RECTAL ULTRASOUND (TRUS) MEA-
SUREMENT AND COMPUTER TOMOGRAPHY (CT) SCAN MEASUREMENT
OF PROSTATE SIZE
J. Filby*, O. Aboumarzouk, C. Bates. Royal Gwent Hospital, South Wales, UK.
Aim: To determine accuracy of calculated measurements of the prostate
gland utilising existing CT scans were concordant with TRUS measure-
ments provided by the same unit.
Background: When assessing risk of developing prostate cancer, the size
of the prostate is a key factor. TRUS biopsy is currently the gold standard
for diagnosing prostate cancer. It is possible to calculate prostate size by
extrapolation from CT scans of the pelvis.
Method: I carried out a Retrospective study of 1200 patients who under-
went TRUS biopsy in Royal Gwent Hospital. Patients who received a CT
scan within 1 year of TRUS biopsy. Approximate volume of the prostate
was calculated from the contours of the prostate on CT scan drawn by one
physician, who was unaware of the TRUS volume calculation, using axial
CT images.
Result: Of our sample population, 1 in 5 patients who underwent TRUS
biopsy and measurement had also received a CT scan within 1 year.
Comparing TRUS measurement with calculated CT measurement provided
a pearsons correlation co-efﬁcient of 0.93 indicating strong positive cor-
relation in this sample.
Conclusion: CT scan volumes andmeasurements correlate well with those
obtained by TRUS. To calculate risk of prostate cancer in patients CT images
can be used in the absence of TRUS measurement.http://dx.doi.org/10.1016/j.ijsu.2016.08.450
0267: POST-OPERATIVE BLOOD TESTS IN PATIENTS UNDERGOING URO-
LOGICAL SURGERY
P. Ravindra*, G. Lam, M.A.W. Miller. Northampton General Hospital,
Northampton, UK.
Most urological procedures have a low rate of complications. There is no
guidance in the literature on which patients should have post-operative
blood tests (POBT). We aimed to quantify their incidence and to establish if
patient management was consequently changed.
All adult patients undergoing Grade 1-3 urological procedures spending
1 night in hospital over 3 months was identiﬁed. Day 1 POBT incidence
was recorded. The consequence of abnormal results was investigated.
171 patients satisﬁed the inclusion criteria. Median length of stay: 1 day
(range 1-27). 94/171 patients underwent POBT, mainly FBC & U&E (92/94).
There was a signiﬁcant difference between pre-operative and post-oper-
ative sodium (average drop 2.02mmol/L [p¼0.0004]) but no signiﬁcant
difference with haemoglobin/creatinine (p>0.05). No patients received an
unplanned transfusion. One patient was diagnosed with new severe
hyponatraemia after a prolonged TURBT. The total cost of these tests was
£854.02 (annually £3416.08). >90% of results were reported after 11AM
thus delaying patient discharge.
There are a considerable number of POBT performed with no clinical
indication. The authors recommend a patient-speciﬁc approach based on
intra-operative judgement and clinical assessment. This would result insavings to the Trust both in terms of laboratory requirements and patient
ﬂow whilst maintaining safe practice.http://dx.doi.org/10.1016/j.ijsu.2016.08.451
0300: THE EFFICACY OF THULIUM LASER VAPO-ENUCLEATION IN PA-
TIENTS WITH LARGE VOLUME PROSTATES: OUTCOMES FROM A SINGLE
UK CENTRE
M.Wanis*, T. Seevagan, F. Alibeygi, M. Khan. University Hospitals of Leicester,
Leicester, UK.
Introduction: Laser transurethral prostatectomy (TURP) is increasingly
becoming the surgical treatment of choice for men with bladder outﬂow
obstruction (BOO) or acute urinary retention (AUR). However, its efﬁcacy
in men with larger prostates is less established. We determined the efﬁ-
cacy of thulium vapo-enucleation (ThuVEP) in patients presenting with
BOO+/-AUR and large volume prostates.
Method: From 2012-2015, 26 men with prostate volumes> /¼70cc
conﬁrmed on transrectal ultrasound underwent ThuVEP for BOO or AUR
by a single surgeon. Outcomes were measured using the International
Prostate Symptom Score (IPSS) and Quality of Life (QoL) score.
Result:Median follow-up was 16 months. 58% of patients had AUR and 42%
had BOO proven on urodynamics. Mean prostate volume was 113cc (range:
70cc-194cc) and mean PSA was 7.9ng/ml (range: 0.9e24ng/ml). Mean
maximum ﬂow rate was 9.4ml/s and post-void residual volume 309ml.
There was a signiﬁcant improvement in both IPSS and QoL scores post-
operatively (p<0001 for both). 93% of patients with AUR had a successful
trialwithout catheter post-operatively.Mean length of staywas1.6 days. No
patients required blood transfusion and there were no cases of urosepsis.
Conclusion: Our study demonstrates that ThuVEP is safe and effective in
men with BOO+/-AUR and large volume prostates.http://dx.doi.org/10.1016/j.ijsu.2016.08.452
0306: PROSTATE-SPECIFIC ANTIGEN TESTING IN THE COMMUNITY: IF
WE ARE DOING IT, LET'S DO IT RIGHT
D. Challoumas 1,*, M. Stoddart 1, J. Beaven 2, J. Phull 1, J. McFarlane 1. 1Royal
United Hospital Bath, Bath, UK; 2Beckington Family Practice, Beckington, UK.
Introduction: The present retrospective study aimed to assess the use of
PSA testing in primary care, identify potential problems and deﬁciencies,
and introduce simple strategies to improve practice.
Method: We searched the databases of two family practices in October
2015 and identiﬁed all patients who had a PSA test in the previous 6weeks.
We then conducted a detailed assessment of each PSA test based on the
doctors' documentation.
Result: A total of 153 patients with a recent PSA test were identiﬁed in the
two practices. In the majority of cases, the indication was either moni-
toring of known prostate cancer (39%) or lower urinary tract symptoms
(36%), while the indication was unclear in 7 patients (5%). Where appli-
cable, a UTI and vigorous exercise/sexual activity within 48 hours before
the test were excluded in 34% and 7% of cases respectively. Counselling was
offered in 8% of patients, risk assessment was performed in 5% of patients
and life expectancy was not considered in any patients.
Conclusion: Based on the disappointing percentages identiﬁed, we
implemented a risk assessment template and other simple strategies
aiming to facilitate decisions about the appropriateness of both the per-
formance of PSA tests and referral to secondary care.http://dx.doi.org/10.1016/j.ijsu.2016.08.453
0350: PATIENT SATISFACTION WITH INTRAVESICAL BOTULINUM TOXIN
INJECTION UNDER LOCAL ANAESTHETIC: A SERVICE IMPROVEMENT
PROJECT IN A REGIONAL UNIT
P. Burnell*, T. Page, A. Thorpe, C. Harding. The Freeman Hospital, Newcastle
Upon Tyne, UK.
Abstracts / International Journal of Surgery 36 (2016) S31eS132 S123Aim: Intravesical injections of botulinium toxin type A can be offered for
refractory symptoms of overactive bladder. This project aimed to:
(1) Assess patient satisfaction with intravesical injections admin-
istered under local anaesthetic.
(2) Evaluate service change within this Regional Unit.
(3) Use outcome tso improve service delivery.
Method: 38 patients received injections under LA November-April 2014.
During post-treatment telephone review, patients completed:
(i) the validated TSQM patient satisfaction questionnaire
(ii) a ‘recommend to a friend’ Analogue Scale
(iii) a Likert-type scale for LA versus GA
Quality of life pre and post-procedure was evaluated using ICIQ-LUTS.
Four-domain TQSM scores were calculated. T-Test was performed on pre-
and-post injection LUTS scores.
Result: Twenty-ﬁve patients were successfully contacted. Validated TSQM
questionnaires revealed a mean of 80% of the maximum score for clinical
effectiveness (SD 21). Overall global satisfaction was 78%. Fifty-six percent
of patients indicated a preference for GA compared with LA. Patients
expressing a preference for LA had greater symptom improvement.
Conclusion: Botox injections administered under LA were effective,
demonstrated by the improvement in LUTS scores and the high level of
satisfaction. A majority expressed a preference for LA; the greater symp-
tom improvement in this group may be a confounding factor.http://dx.doi.org/10.1016/j.ijsu.2016.08.454
0352: AN IRISH PROSTATE CANCER RISK CALCULATOR
R. Foley 1,*, K. Murphy 2, R. Maweni 3, T. Lynch 4, R. Power 4, G. Durkan 4,
F. O'Brien 4, K. O'Malley 4, D. Galvin 4, T. Brendan Murphy 2, R. William
Watson 1. 1 School of Medicine, University College Dublin, Ireland; 2 School of
Mathematical Sciences, University College Dublin, Ireland; 3Croydon
University Hospital, London, UK; 4 Irish Prostate Biopsy Collaborative, Ireland.
Introduction:Accurate risk stratiﬁcation of patients pre-biopsy is essential
for the diagnosis of prostate cancer (PCa). The objective of this studywas to
build a risk calculator to facilitate the decision for prostate biopsy in
Ireland.
Method: The clinical information of 4,808 patients from 8 Irish tertiary
centres was analysed. A risk calculator for the diagnosis of PCa and another
for the diagnosis of high grade (Gleason 7) PCa were created via logistic
regression. The components of the risk calculators are age, digital rectal
examination, family history, prior negative biopsy and PSA level.
Result: The Irish PCa Risk Calculator achieved AUC values of 0.67 and 0.73
in the prediction of PCa and high grade PCa respectively. This was a sta-
tistically signiﬁcantly improvement over PSA (p<0.01) with AUC values for
PSA of 0.60 and 0.66 for the prediction of PCa and high grade PCa. The Irish
PCa risk calculator also demonstrated a net beneﬁt on decision curve
analysis and a suitable calibration in each cohort.
Conclusion: An Irish PCa risk calculator created from a national collection
of patients can allow for individualised risk stratiﬁcation and can be used
to improve clinical decision-making in Irish men under investigation for
PCa.http://dx.doi.org/10.1016/j.ijsu.2016.08.455
0366: IMPROVING MULTIVARIABLE PROSTATE CANCER RISK
ASSESSMENT
R. Maweni 1,*, R. Foley 2, K. Murphy 3, G. Durkan 4, R. Power 4, F. O'Brien 4,
K. O'Malley 4, D. Galvin 4, B. Murphy 3, W. Watson 2. 1Croydon University
Hospital, London, UK; 2University College Dublin, School of Medicine, Dublin,
Ireland; 3 School of Mathematical Sciences, University College Dublin, Dublin,
Ireland; 4 Irish Prostate Biopsy Collaborative, Dublin, Ireland.Introduction: In order to diagnose prostate cancer (PCa) effectively, the
best possible risk factors should be utilised. We assessed the performance
of two well-validated PCa risk calculators to analyse the use of prostate
volume and a novel PCa biomarker (pro-PSA) in PCa prediction.
Method: The risk of high-grade PCa (Gleason 7) in 2,001 patients from 6
tertiary referral centres was calculated according to the two PCa risk cal-
culators. Predictions were analysed using ROC analysis, calibration analysis
and decision curve analysis. In a subset of 222 patients, risk predictions
were calculated that included pro-PSA.
Result: The addition of prostate volume signiﬁcantly improved the per-
formance of high-grade PCa prediction, with an AUC of 0.74 compared to
0.69 (p<0.001). The addition of pro-PSA further improved risk prediction
with an AUC of 0.78 compared to 0.72 (p¼0.04).
Conclusion: The performance of these PCa risk calculators demonstrates
that prostate volume has the potential to improve PCa diagnosis. Further-
more, the incorporation of the pro-PSA allowed each patient’s risk to be
more accurately quantiﬁed. Individual patient risk calculation using prostate
volume and pro-PSA can be undertaken in order to allow for a systematic
approach to patient risk stratiﬁcation and to aid in the diagnosis of PCa.http://dx.doi.org/10.1016/j.ijsu.2016.08.456
0376: REJECTING REFERRALS FOR ASYMPTOMATIC NON-VISIBLE HAE-
MATURIA: IMPLICATIONS OF A CHANGE IN PRACTICE
M. Kamarizan*, A. Cox, M. Hunter, J.R. Wilson, D.J. Painter, A.C. Carter. Royal
Gwent Hospital, Newport, UK.
Introduction: The NICE NG12 guidance for urgent suspected cancers(USC)
suggests that asymptomatic non-visible haematuria(aNVH) need not be
seen as USC. Whilst implementing NG12, we also present the early
outcome of rejecting referrals for aNVH entirely.
Method: USC haematuria referrals to a large district general hospital from
April to November 2015 were strictly vetted prospectively against NG12
recommendations, and compared to data from a similar time period prior to
implementation. Simultaneously aNVH referrals were rejected in writing.
Result: In 8 months, 676 patients were seen in a one stop haematuria clin-
ic(OSHC); 352 pre-NG12 implementation(cohort 1), and 324 after-
wards(cohort 2). In cohort 1, 212 had visible haematuria(VH), and 140 had
non-visible haematuria(NVH) with 34 cancers diagnosed. Thirteen of these
were either high risk non-muscle invasive(HRNMIBC) or muscle invasive(-
MIBC)bladdercancer.Of thosewithNVH,only1 lowrisknon-muscle invasive
bladder cancer(LRNMIBC) was diagnosed. In cohort 2, 39 cancers were
diagnosed; 11 HRNMIBC and 4 MIBC. Seventy-six aNVH referrals were
rejected.Average referral to treatment timeimprovedfrom39days to18days.
Conclusion: No signiﬁcant tumour was found in patients referred with
aNVH pre-implementation. After implementation, and rejecting patients
with aNVH, patients with bladder cancer were seen and treated earlier.http://dx.doi.org/10.1016/j.ijsu.2016.08.457
0433: PROCEDURES FOR PENILE STRICTURES: OPTIONS AND OUT-
COMES AT 7 YEARS
D. Evans*, I. Rudd, R. Krishnan. Kent & Canterbury Hospital, Canterbury, Kent,
UK.
Aim: Penile urethral strictures can be treated by a variety of procedures,
often in tertiary care centres. We present our experience and outcomes
over a 7 year period at a District General Hospital.
Method: Between November 2008 and December 2015, 101 operations
were performed by a single surgeon in seventy patients with penile ure-
thral strictures. Twenty also had bulbar urethral involvement. Procedures
included two-stage urethroplasty with buccal mucosal graft (BMG) (49
ﬁrst/31 second stage), single stage dorsal BMG urethroplasty (4), Orandi
patch (5), meatotomy (7), and perineal urethrostomy (5). Median age was
51.3 years and median stricture length was 5cm.
Result: 30% of penile strictures were iatrogenic, 30%were BXO-related, and
24% were failed hypospadias repairs. A successful outcome was seen in
90%. Four patients (5.7%) required minor revision prior to ﬁnal
